BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. CRWV
8. MSFT
9. MH
10. DLMAF

Go back to BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights

BioXcel Therapeutics (BTAI) Misses Q2 EPS by 15c

August 9, 2022 7:23 AM EDT

BioXcel Therapeutics (NASDAQ: BTAI) reported Q2 EPS of ($1.35), $0.15 worse than the analyst estimate of ($1.20).

For earnings history and earnings-related data on BioXcel Therapeutics (BTAI) click here.

... More